5 months ago
KOD
AnalystsDaniil GataulinDaniil Gataulin's Stock Forecasts
AnalystsDaniil Gataulin
Sectors:
Industries:
Analyst Ranking
Top 3%
#154 out of 5539 analysts
Average Return
+34.81%
Win Rate
52%74 out of 142
Risk vs Reward
Poor
Good
Daniil Gataulin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Eyepoint IncEYPT | +758.90% | $3.26 | $28.00 | 2023-03-03 - 2024-03-01 | Strong Buy |
Forte Biosciences IncFBRX | +564.04% | $11.57 | $76.83 | 2025-08-15 - 2026-08-14 | Strong Buy |
Forte Biosciences IncFBRX | +431.33% | $14.49 | $76.99 | 2025-11-17 - 2026-08-27 | Strong Buy |
Cognition Therapeutics IncCGTX | +251.52% | $0.33 | $1.16 | 2025-05-08 - 2026-05-07 | Strong Buy |
Cognition Therapeutics IncCGTX | +249.58% | $0.47 | $1.65 | 2024-10-31 - 2025-10-30 | Strong Buy |
Daniil Gataulin Analyst Color
Get additional color on Daniil Gataulin's coverage of popular stocks
7 months ago
CRVO
7 months ago
QURE
7 months ago
EYPT
a year ago
OCS
2 years ago
CRVO
2 years ago
OCGN
3 years ago
ADVM
Daniil Gataulin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Kodiak Sciences IncKOD | 5 | Strong Buy | $61.00 | -38.55% | Upgrades | 5 months ago |
Uniqure NvQURE | 14 | Strong Buy | $37.00 | +69.41% | Maintains | 5 months ago |
Cognition Therapeutics IncCGTX | 9 | Strong Buy | $4.00 | +366.74% | Maintains | 7 months ago |
Meiragtx Holdings PLCMGTX | 8 | Strong Buy | $35.00 | +237.19% | Maintains | 7 months ago |
Ocugen IncOCGN | 17 | Strong Buy | $7.00 | +639.18% | Maintains | 7 months ago |
Zura Bio LtdZURA | 4 | Strong Buy | $11.00 | +175.00% | Maintains | 7 months ago |
Annexon IncANNX | 2 | Strong Buy | $16.00 | +304.04% | Maintains | 7 months ago |
Cervomed IncCRVO | 9 | Strong Buy | $21.00 | +736.65% | Maintains | 7 months ago |
Opus Genetics IncIRD | 4 | Strong Buy | $11.00 | +137.07% | Maintains | 7 months ago |
Eyepoint IncEYPT | 13 | Strong Buy | $29.00 | +773.49% | Maintains | 7 months ago |
Outlook Therapeutics IncOTLK | 12 | Hold | $1.00 | +70.94% | Maintains | 8 months ago |
Ocular Therapeutix IncOCUL | 5 | Strong Buy | $21.00 | +177.78% | Maintains | 8 months ago |
Regenxbio IncRGNX | 16 | Strong Buy | $50.00 | +543.50% | Maintains | 8 months ago |
Kalaris Therapeutics IncKLRS | 1 | Strong Buy | $19.00 | +740.71% | Initiates Coverage On | 10 months ago |
Forte Biosciences IncFBRX | 6 | Strong Buy | $61.00 | -20.77% | Maintains | a year ago |
Oculis Holding AgOCS | 8 | Strong Buy | $51.00 | +547.21% | Maintains | a year ago |
Tourmaline Bio IncTRML | 4 | Hold | $48.00 | N/A | Downgrades | a year ago |
Adverum Biotechnologies IncADVM | 6 | Strong Buy | $33.00 | N/A | Maintains | a year ago |
Unity Biotechnology IncUNBX | 4 | Strong Buy | $4.00 | N/A | Maintains | a year ago |
Clearside Biomedical IncCLSDQ | 4 | Strong Buy | $90.00 | N/A | Maintains | 2 years ago |
Purple Biotech LtdPPBT | 1 | Strong Buy | $2,200.00 | N/A | Maintains | 3 years ago |
Korro Bio IncKRRO | 1 | Strong Buy | $7.00 | N/A | Initiates Coverage On | 4 years ago |
Oyster Point Pharma IncOYST | 2 | Hold | $13.00 | N/A | Downgrades | 4 years ago |
Applied Genetic Technologies CorpAGTC | 2 | Strong Buy | $3.00 | N/A | Maintains | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.